In an in vitro study, hypermethylation of the excitatory amino acid transporter (EAAT2) promoter in glioma cells led to a deficiency in astroglial EAAT2 expression, which was related to the pathogenesis of CNS disorders with remarkable excitatory toxicity elements. Here, SLC1A2 is linked to central nervous system cancer.